Madridge logo

Madridge

We publish journals with a view to serve various purposes which include but not limited to just peer review, broad distribution, branding and authority, portability and creation of the archive of a body of literature....

User Pic

Editor Name: Vaishali Kapoor

Designation: Research associate

University: University of Washington

Country: USA

Biography: Vaishali Kapoor earned her Ph.D from the All India Institute of Medical Sciences, New Delhi. She is currently a postdoc in the Department of Radiation Oncology, Washington University in St. Louis School of Medicine. Her research involves development of novel drug candidates against radiation-inducible neo-antigens. Radiation treatment induces cell-surface expression of novel intracellular proteins. Several peptides have been identified and monoclonal antibodies have been generated against these antigens. Her aim is to identify and characterize a lead peptide and antibody which can be used for pre-clinical efficacy studies and then be extended to the clinic. In addition to the drug-discovery research, she is trying to understand the biological mechanisms involved in development of radiation-induced lymphopenia. She has successfully developed a mouse-model for radiation-induced lymphopenia. Using this in vivo model we have shown for the first time that radiation induces lymphopenia by both direct and indirect effects on the bone marrow stem cells

User Pic

Editor Name: Vaishali Kapoor

Designation: Scientist

University: Washington University School of Medicine

Country: India

Biography: Vaishali Kapoor earned her Ph.D from the All India Institute of Medical Sciences, New Delhi. She completed her postdoc in the Department of Radiation Oncology, Washington University in St. Louis School of Medicine. Her research involves development of novel drug candidates against radiation-inducible neo-antigens. Radiation treatment induces cell-surface expression of novel intracellular proteins. Several peptides have been identified and monoclonal antibodies have been generated against these antigens. Her aim is to identify and characterize a lead peptide and antibody which can be used for pre-clinical efficacy studies and then be extended to the clinic.  In addition to the drug-discovery research, she is trying to understand the biological mechanisms involved in development of radiation-induced lymphopenia.


Publication Cycle →

Submission
Quality Check
Peer Review
Editor's Decision
Acceptance
Publishing